Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey
MUMBAI, India, Aug. 26, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released its Sustainability Report 2025–26, showcasing significant progress across its environmental, social and governance (ESG) priorities. Anchored by the theme "Advancing Innovation, Leveraging Sustainability," the report highlights how sustainability continues to be integrated into the Company's strategy, operations and innovation agenda while creating long-term value for patients, customers, communities and stakeholders.
Key Highlights:
Climate and Responsible Operations
- Achieved a 22.6% reduction in Scope 1 and Scope 2 greenhouse gas emissions compared to the FY2022 baseline
- Increased renewable energy usage to 41% of total energy consumption across operations
- Recycled and reused 2.63 Lakh kilolitres of freshwater, and diverted 65% of total waste for recycling
- Continued progress against the Company's Science Based Targets initiative (SBTi)-approved decarbonisation roadmap
Quality and Operational Excellence
- Successfully completed 38 regulatory inspections, including three USFDA inspections with zero Official Action Indicated (OAI) observations
- Completed 209 customer audits, reinforcing the Company's quality and compliance standards across its global manufacturing network
- Advanced enterprise-wide digital transformation through Catalyst NxGen, SAP S/4HANA implementation and expansion of digital quality systems
- Announced a US$90 million investment to expand advanced therapeutics capabilities at its Lexington and Riverview facilities
Governance and People
- Maintained zero data breach incidents and zero corruption cases during the reporting period
- Achieved 100% ESG training completion across employees and 100% Code of Conduct training for the workforce
- Women represented 30% of the Board and 20.1% of the global workforce, reflecting continued progress on diversity and inclusion
- Assessed 38% of critical suppliers against sustainability criteria as part of the Company's responsible supply chain programme
Community Impact

